Qarziba (dinutuximab beta)

News alerts, weekly reports and conference planners

Company:

Apeiron Biologics, BeiGene, Jazz

Drug class:

GD2 ganglioside inhibitor

Related drugs:

No biomarker	Neuroblastoma	No biomarker	Neuroblastoma	dinutuximab beta Sensitive: A1 - Approval dinutuximab beta Sensitive : A1	dinutuximab beta Sensitive: A1 - Approval dinutuximab beta Sensitive : A1
B4GALNT1 expression	Ewing Sarcoma	B4GALNT1 expression	Ewing Sarcoma	dinutuximab beta Sensitive: C3 – Early Trials dinutuximab beta Sensitive : C3	dinutuximab beta Sensitive: C3 – Early Trials dinutuximab beta Sensitive : C3

Associations
(2)